Beneficial Effects of Pioglitazone on Retardation of Persistent Atrial Fibrillation Progression in Diabetes Mellitus Patients-Reference-Cited by-同舟云学术

Beneficial Effects of Pioglitazone on Retardation of Persistent Atrial Fibrillation Progression in Diabetes Mellitus Patients

Published:2014 Issue:6 Volume:55 Page:499-505
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Liu Bing¹,Wang Jiancheng²,Wang Guoxing¹

Affiliation:

1. Department of Emergency, Beijing Friendship Hospital, Capital Medical University

2. Department of Clinical Laboratory, Beijing Friendship Hospital, Capital Medical University

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/55/6/55_14-107/_pdf

Reference57 articles.

1. 1. Lip GY, Varughese GI. Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. Int J Cardiol 2005; 105: 319-21.

2. 2. Kato T, Yamashita T, Sekiguchi A, et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 2006; 17: 890-4.

3. 3. Swartz MF, Fink GW, Sarwar MF, et al. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. J Am Coll Cardiol 2012; 60: 1799-806.

4. 4. Goette A. Upstream therapy for atrial fibrillation in heart failure. Heart Fail Clin 2013; 9: 417-25. (Review)

5. 5. Tziakas DN, Chalikais GK, Stakos DA, et al. Effect of angiotensin-converting enzyme insertion/deletion genotype on collagen type I synthesis and degradation in patients with atrial fibrillation and arterial hypertension. Expert Opin Pharmacother 2007; 8: 2225-34.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lifestyle changes in atrial fibrillation management and intervention;Journal of Cardiovascular Electrophysiology;2023-01-14

2. Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists;Diabetes & Metabolism;2022-11

3. An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes;Medicina;2022-10-17

4. Epicardial fat and atrial fibrillation: the perils of atrial failure;EP Europace;2022-03-11

5. Methods to investigate advanced glycation end-product and their application in clinical practice;Methods;2021-12